The pharmaceutical industry is targeting vulnerable Americans with predatory pricing that is forcing them to ration life-saving drugs, according to a three-year congressional probe released Friday.
Dec 10, 2021
0
13
Aduhelm, the first new Alzheimer's drug in 18 years, could easily become the best-selling drug in Medicare, despite its potential massive cost and tremendous uncertainty about whether the drug even works, says Rachel Sachs, ...
Dec 7, 2021
1
3
A measure designed to lower prescription drug costs for seniors has been added to President Joe Biden's social safety net and climate change bill that Democratic leaders hope to bring to a House vote this week.
Nov 3, 2021
0
1
Average annual health care spending for individuals with employer-sponsored insurance (ESI) rose 2.9% to $6,001 per person in 2019, according to the Health Care Cost Institute's annual Health Care Cost and Utilization Report. ...
Oct 6, 2021
0
7
Basing new drug launch prices on historical domestic data could limit manufacturers' power to set extremely high launch prices and could reduce Medicare spending on new drugs by up to 30%, according to a new white paper released ...
Sep 23, 2021
0
13
Linking the cost of prescription drugs in the United States to the prices paid in other high-income nations could have reduced American spending for the drugs by at least half in 2020, according to a new RAND Corporation ...
Sep 10, 2021
0
3
A new analysis of publicly reported financial information of the pharmaceutical industry finds reducing drug prices could have no impact to future drug approvals.
Aug 12, 2021
0
2
Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages ...
Aug 10, 2021
0
54
UK policymakers preparing trade deals post-Brexit can learn important lessons from New Zealand's 'unique drug agency' the Pharmaceutical Management Agency (PHARMAC), if prices for therapies and access to key drugs are to ...
Jul 19, 2021
0
1
Italian pharmaceutical Leadiant has been fined almost 20 million euros for allegedly overcharging for medicine used to treat a rare cholesterol disease, the Dutch consumer watchdog said on Monday.
Jul 19, 2021
0
1
